EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells

Tien-Chun Yang iD, Mei-Hua Lu, Wei-Jie Wang, Jang-Yi Chen

Journal of Molecular Endocrinology · 2023

DOI: 10.1530/jme-22-0178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, 2023. Verfasst von Tien-Chun Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Hypertension. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of hypertension is not fully understood; endothelin 1 (EDN1) is involved in developing essential hypertension. EDN1 can promote vascular smooth muscle cell (VSMC) proliferation or hypertrophy through autocrine and paracrine effects. Proliferating smooth muscle cells in the aorta are 'dedifferentiated' cells that cause increased arterial stiffness and remodeling. Male SHRs had higher aortic stiffness than normal control male WKY rats. Male SHR VSMCs expressed high levels of the EDN1 gene, but endothelial cells did not. Therefore, it is necessary to understand the molecular mechanism of enhanced EDN1 expression in SHR VSMCs. We identified POU2F2 and CEBPB as the main molecules that enhance EDN1 expression in male SHR VSMCs. A promoter activity analysis confirmed that the enhancer region of the Edn1 promoter in male SHR VSMCs was from −1309 to −1279 bp. POU2F2 and CEBPB exhibited an additive role in the enhancer region of the EdnET1 promoter. POU2F2 or CEBPB overexpression sufficiently increased EDN1 expression, and co-transfection with the CEBPB and POU2F2 expression plasmids had additive effects on the activity of the Edn1 promoter and EDN1 secretion level of male WKY VSMCs. In addition, the knockdown of POU2F2 also revealed that POU2F2 is necessary to enhance EDN1 expression in SHR VSMCs. The enhancer region of the Edn1 promoter is highly conserved in rats, mice, and humans. POU2F2 and CEBPB mRNA levels were significantly increased in remodeled human VMSCs. In conclusion, the novel regulation of POU2F2 and CEBPB in VSMCs will help us understand the pathogenesis of hypertension and support the development of future treatments for hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularHypertensionRatsMaleHumansMiceAnimalsRats, Inbred WKYRats, Inbred SHREndothelin-1Endothelial CellsMyocytes, Smooth MuscleCells, CulturedOctamer Transcription Factor-2CCAAT-Enhancer-Binding Protein-beta

Stichwörter der Autor:innen

aortaendothelin 1hypertensionspontaneously hypertensive ratsvascular smooth muscle cell

Substanzen

Endothelin-1POU2F2 protein, humanOctamer Transcription Factor-2CEBPB protein, humanCCAAT-Enhancer-Binding Protein-betaPou2f2 protein, rat

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan.
  • Department of Entomology, University of California, Riverside, California, USA.

ORCID-Profile: Tien-Chun Yang

Zitieren

APA

Yang, T. C., Lu, M. H., Wang, W. J., & Chen, J. Y. (2023). CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells. Journal of Molecular Endocrinology. https://doi.org/10.1530/jme-22-0178

Vancouver

Yang TC, Lu MH, Wang WJ, Chen JY. CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells. Journal of Molecular Endocrinology. 2023. doi:10.1530/jme-22-0178

BibTeX
@article{Yang2023,
  author = {Yang, Tien-Chun and Lu, Mei-Hua and Wang, Wei-Jie and Chen, Jang-Yi},
  title = {CEBPB/POU2F2 modulates endothelin 1 expression in prehypertensive SHR vascular smooth muscle cells},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  doi = {10.1530/jme-22-0178}
}
Kostenlos starten →